Acknowledgement
We thank Professor Jeong-Ju Yoo, MD, PhD, for her dedication and support of this study.
References
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596-646. https://doi.org/10.1161/CIR.0000000000000725
- Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2018;379:633-44. https://doi.org/10.1056/NEJMoa1800256
- Wright AK, Suarez-Ortegon MF, Read SH, et al. Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings. Circulation 2020;142:1925-36. https://doi.org/10.1161/CIRCULATIONAHA.120.046783
- Hwang IC, Kim CH, Kim JY, Choi HM, Yoon YE, Cho GY. Rate of change in 10-year atherosclerotic cardiovascular disease risk and its implications for primary prevention. Hypertension 2023;80:1697-706. https://doi.org/10.1161/HYPERTENSIONAHA.122.20678
- Seong SC, Kim YY, Park SK, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open 2017;7:e016640.